Escient Pharmaceuticals picks up Series B
San Diego-based Escient Pharmaceuticals Inc, a biotech firm, has secured $77.5 million in Series B financing.
San Diego-based Escient Pharmaceuticals Inc, a biotech firm, has secured $77.5 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination